The mycophenolate mofetil treatment utility for diffuse proliferative lupus nephritis class IV (WHO) in patients without control disease activity.

被引：0
|
作者：
Pérez, CM [1 ]
Gonzalez, SL [1 ]
Camargo, CA [1 ]
Hernandez, VR [1 ]
Canul, NE [1 ]
Fernandez, AG [1 ]
Ake, UM [1 ]
Medina, RF [1 ]
Fraga, MA [1 ]
机构：
[1] Ctr Med Nacl Siglo XXI, IMSS, Mexico City, DF, Mexico
来源：
JOURNAL OF RHEUMATOLOGY | 2006年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 50 条
  • [41] The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
    Meng-Yu Weng
    Chia-Tse Weng
    Ming-Fei Liu
    [J]. Clinical Rheumatology, 2010, 29 : 771 - 775
  • [42] Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis
    Takayuki Katsuno
    Takenori Ozaki
    Takaya Ozeki
    Asaka Hachiya
    Hangsoo Kim
    Noritoshi Kato
    Takuji Ishimoto
    Sawako Kato
    Tomoki Kosugi
    Naotake Tsuboi
    Masashi Mizuno
    Yasuhiko Ito
    Shoichi Maruyama
    [J]. Clinical and Experimental Nephrology, 2018, 22 : 1341 - 1350
  • [43] Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria
    Kasitanon, Nuntana
    Boripatkosol, Pornkamon
    Louthrenoo, Worawit
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (01) : 199 - 206
  • [44] Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis
    Katsuno, Takayuki
    Ozaki, Takenori
    Ozeki, Takaya
    Hachiya, Asaka
    Kim, Hangsoo
    Kato, Noritoshi
    Ishimoto, Takuji
    Kato, Sawako
    Kosugi, Tomoki
    Tsuboi, Naotake
    Mizuno, Masashi
    Ito, Yasuhiko
    Maruyama, Shoichi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (06) : 1341 - 1350
  • [45] The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
    Weng, Meng-Yu
    Weng, Chia-Tse
    Liu, Ming-Fei
    [J]. CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 771 - 775
  • [46] Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman
    Fliesser, E. E.
    Korsten, P.
    Koziolek, M. J.
    Niewold, T. B.
    Patschan, D.
    Mueller, G. A.
    Patschan, S. A.
    [J]. LUPUS, 2013, 22 (14) : 1523 - 1525
  • [47] Mycophenolate mofetil: A potential treatment for diffuse prolipherative lupus nephritis (DPLN) and chronic hepatitis C virus infection.
    Medina, F
    Fuentes, J
    Carranza, I
    Portela, M
    Barile, L
    Fraga, A
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S415 - S415
  • [48] Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
    Domenico Paolo Emanuele Margiotta
    Fabio Basta
    Veronica Batani
    Antonella Afeltra
    [J]. BMC Nephrology, 19
  • [49] Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
    Margiotta, Domenico Paolo Emanuele
    Basta, Fabio
    Batani, Veronica
    Afeltra, Antonella
    [J]. BMC NEPHROLOGY, 2018, 19
  • [50] Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression
    Mak, Anselm
    Cheak, Alicia A. C.
    Tan, Jason Y. S.
    Su, Hnin Cho
    Ho, Roger C. M.
    Lau, Chak Sing
    [J]. RHEUMATOLOGY, 2009, 48 (08) : 944 - 952
12345